M2 TONE SYRUP

Indications

• Type 2 diabetes management
• Digestive disorders
• Anti-inflammatory support
• Antioxidant activity
• Weight management
• Blood sugar regulation

Dosage

Children: Refer to established guidelines for specific dosing based on the formulation and intended use.

Adults: Refer to established guidelines for specific dosing based on the formulation and intended use.

Mechanism of action

The active compounds in cassia, particularly cinnamaldehyde and coumarin, may exert their effects by modulating various metabolic pathways. Cinnamaldehyde has been shown to enhance insulin sensitivity, thereby improving glucose uptake in cells. The antioxidant properties of cassia may help reduce oxidative stress, which is implicated in various chronic diseases. Coumarin has been associated with anti-inflammatory effects and may influence blood coagulation pathways.

Pharmacodynamics

Cassia exhibits a range of pharmacodynamic effects primarily due to its bioactive compounds. Its anti-inflammatory properties can contribute to reduced inflammation markers in the body. The ability of cassia to potentially lower blood glucose levels is of particular interest, especially in the management of type 2 diabetes. Additionally, its antioxidant effects help protect cells from damage caused by free radicals.

Pharmacokinetics

The pharmacokinetics of cassia components can vary based on the specific compounds and their formulations. Generally, compounds like cinnamaldehyde are absorbed in the gastrointestinal tract and metabolized in the liver. The half-life and excretion pathways can vary, but many of the bioactive constituents are rapidly metabolized and eliminated. The systemic bioavailability of these compounds can be influenced by factors such as the form of cassia consumed and the presence of other dietary components.

Adverse effects

• Gastrointestinal upset
• Diarrhea
• Abdominal cramps
• Electrolyte imbalance
• Dehydration

Interactions

• May enhance the effect of diuretics
• May interact with medications that affect electrolyte levels

Precautions

• Use with caution in individuals with gastrointestinal disorders
• Monitor electrolyte levels in prolonged use
• Not recommended for long-term use

Pregnancy

Cassia is generally not recommended during pregnancy due to a lack of safety data. Consult a healthcare provider for guidance.

Breast-feeding

Use with caution while breastfeeding. Consult a healthcare provider before use.

Storage

Store in a cool, dry place, away from direct sunlight.

Formulations

• Dried leaves
• Powdered form
• Tea preparations

Indications

• Loss of appetite
• Digestive disorders
• Fever
• Liver disorders
• Malaria (traditional use)

Dosage

Children: Refer to established herbal guidelines and consult with a healthcare professional for appropriate dosing.

Adults: Refer to established herbal guidelines and consult with a healthcare professional for appropriate dosing.

Mechanism of action

Chiraita contains bioactive compounds such as swertiamarin, which are believed to exert their effects through several pathways. These compounds may enhance bile secretion, facilitate digestion, and exhibit hepatoprotective properties. The bitter principles in chiraita are thought to stimulate the secretion of gastric juices, thereby improving digestive processes and appetite.

Pharmacodynamics

Chiraita exhibits a range of pharmacological effects, including antipyretic, hepatoprotective, and digestive stimulant properties. Its bitter compounds can increase the secretion of digestive enzymes and bile, which aids in digestion and nutrient absorption. Additionally, chiraita may possess antioxidant properties, contributing to its protective effects on the liver and overall health.

Pharmacokinetics

The pharmacokinetics of chiraita are not extensively studied, but it is understood that the active compounds are absorbed in the gastrointestinal tract. The metabolism of these compounds likely occurs in the liver, where they may undergo biotransformation before being excreted. The precise half-life and elimination pathways remain unclear due to limited clinical data.

Contra-indications

• Hypersensitivity to chiraita or any of its components
• Severe liver disease

Adverse effects

• Nausea
• Vomiting
• Diarrhea
• Headache
• Dizziness
• Hypoglycemia

Interactions

• May enhance the effects of antidiabetic medications
• Potential interaction with anticoagulants due to effects on liver metabolism

Precautions

• Use with caution in patients with liver impairment
• Monitor blood sugar levels in diabetic patients

Pregnancy

Limited data available, use only if the benefits outweigh risks.

Breast-feeding

Not well studied, use with caution and consult a healthcare professional.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Powder
• Tablet
• Liquid extract

Indications

• Type 2 diabetes mellitus
• Metabolic syndrome
• Dyslipidemia
• Inflammatory disorders
• Antioxidant support

Dosage

Children: Refer to established guidelines for specific dosing; pediatric use is not well standardized and should be approached with caution.

Adults: Refer to established guidelines for specific dosing; typically, doses range from 1 to 6 grams of cinnamon powder per day.

Mechanism of action

Cinnamon contains bioactive compounds such as cinnamaldehyde, which may enhance insulin sensitivity and improve glucose uptake in cells. It may also exert antioxidant effects and reduce inflammation by modulating various signaling pathways, including the NF-kB pathway.

Pharmacodynamics

The pharmacodynamic effects of cinnamon include modulation of glucose and lipid metabolism, anti-inflammatory effects, and antioxidant activity. Cinnamaldehyde has been shown to activate insulin signaling pathways, thereby improving insulin sensitivity. Additionally, cinnamon may influence the expression of genes involved in glucose metabolism.

Pharmacokinetics

Cinnamon is generally well absorbed when ingested. The bioavailability of its active compounds can vary based on the formulation and method of consumption. Metabolism occurs in the liver, where compounds such as cinnamaldehyde may be transformed into various metabolites. The elimination half-life of cinnamon's active components is not well defined but is expected to vary among individuals.

Adverse effects

• Allergic reactions
• Skin irritation
• Gastrointestinal upset

Interactions

• May enhance the effects of anticoagulants
• Potential interaction with antidiabetic medications

Precautions

• Use with caution in individuals with known allergies to cinnamon or related species
• Monitor blood glucose levels in diabetic patients

Pregnancy

Cinnamon is generally considered safe in food amounts, but high doses should be avoided.

Breast-feeding

Cinnamon in food amounts is likely safe, but high doses should be avoided.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Cinnamon powder
• Cinnamon oil
• Cinnamon extract

Indications

• Inflammation
• Oxidative stress-related conditions
• Metabolic syndrome management
• General health and wellness

Dosage

Children: There is insufficient evidence to recommend a specific pediatric dose for daruhaldi. Consult herbal medicine references or a specialist for guidance.

Adults: Specific dosing information for adults is not well established in clinical guidelines. It is advisable to consult available herbal medicine references or clinical studies for guidance on appropriate dosing based on the preparation used.

Mechanism of action

The mechanisms by which daruhaldi exerts its effects may involve modulation of inflammatory pathways and antioxidant activity. It has been suggested that the active compounds may interact with signaling pathways that regulate oxidative stress and inflammation, possibly contributing to its therapeutic potential.

Pharmacodynamics

Daruhaldi appears to exert its pharmacological effects through a range of bioactive compounds that can influence cellular signaling pathways. These effects may include inhibition of pro-inflammatory cytokines and enhancement of antioxidant defenses, although detailed studies are required to fully elucidate these actions and their implications for clinical use.

Pharmacokinetics

The pharmacokinetics of daruhaldi are not well characterized in the scientific literature. However, like many herbal products, the absorption, distribution, metabolism, and excretion of its active components may vary widely based on formulation, dosage, and individual patient factors. Further research is needed to establish clear pharmacokinetic profiles for the key constituents of daruhaldi.

Pregnancy

The safety of daruhaldi during pregnancy has not been established. It should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known whether daruhaldi is excreted in human milk. Caution should be exercised when administering to breastfeeding women.

Storage

Store at room temperature, away from light and moisture. Keep out of reach of children.

Indications

• Digestive disorders
• Respiratory conditions
• Pain management
• Antimicrobial treatment
• Anti-inflammatory purposes

Dosage

Children: Paediatric dosing information is not specifically available; consult pediatric herbal medicine resources for guidance.

Adults: Dosage varies based on the preparation and condition treated. Generally, refer to traditional usage guidelines or consult herbal medicine resources for specific dosing recommendations.

Mechanism of action

The primary active compounds in kababchini include essential oils such as cubebene and piperine. These compounds exhibit pharmacological effects through various mechanisms, including inhibition of pro-inflammatory cytokines and modulation of pain pathways. Piperine has also been shown to enhance bioavailability of certain drugs by inhibiting drug-metabolizing enzymes.

Pharmacodynamics

Kababchini demonstrates multiple pharmacodynamic effects, including analgesic and anti-inflammatory properties. The herb may affect the central nervous system, leading to a reduction in pain perception. Additionally, its antimicrobial activity is attributed to the presence of essential oils that disrupt microbial cell membranes, leading to cell death.

Pharmacokinetics

The pharmacokinetics of kababchini are not extensively studied. However, it is understood that the active constituents are likely absorbed in the gastrointestinal tract following oral administration. Metabolism may occur in the liver, and elimination primarily happens through renal excretion. The half-life and specific metabolic pathways remain largely uncharacterized in clinical studies.

Pregnancy

There is limited information on the safety of kababchini during pregnancy. Consultation with a healthcare provider is recommended.

Breast-feeding

Caution is advised when administering kababchini during breastfeeding. It is best to consult a healthcare provider.

Storage

Store in a cool, dry place away from direct sunlight and out of reach of children.

Indications

• Fluid retention
• Hypertension
• Urinary tract health
• Kidney function support

Dosage

Children: Specific dosing for paediatric patients is unavailable; consult a healthcare professional for appropriate guidance.

Adults: For adults, the dosage of kasis should be determined based on traditional guidelines or the direction of a healthcare professional, as specific dosing information is not standardized.

Mechanism of action

The exact mechanism of action of kasis is not well-defined in scientific literature. However, herbs like kasis are typically believed to act through the modulation of renal blood flow and promoting diuresis. This can lead to increased urine production and elimination of wastes, potentially contributing to the management of fluid retention and other related conditions.

Pharmacodynamics

Kasis is thought to exert its effects primarily through its active compounds, which may influence renal function and electrolyte balance. The diuretic effect can help reduce blood pressure and alleviate symptoms associated with water retention. However, comprehensive pharmacodynamic studies are limited, and more research is needed to fully understand its efficacy and safety profile.

Pharmacokinetics

Due to the lack of specific pharmacokinetic studies on kasis, detailed information regarding its absorption, distribution, metabolism, and excretion is not available. Generally, herbal products may have variable pharmacokinetics depending on the preparation method and individual patient factors, such as age, weight, and overall health status.

Indications

• Dental pain relief
• Topical antiseptic
• Analgesic for minor aches and pains
• Flavoring agent in culinary applications

Dosage

Children: Refer to the BNF for Children for specific dosing information, as pediatric doses are dependent on age and weight.

Adults: Refer to specific formulations and guidelines for dosing, as recommendations may vary based on indications and preparation.

Mechanism of action

Eugenol, the main component of lavang, exerts its effects primarily through its action as a potent antioxidant and anti-inflammatory agent. It inhibits the activity of cyclooxygenase enzymes (COX-1 and COX-2), which are involved in the inflammatory process. Eugenol also interacts with various ion channels, providing analgesic effects by modulating the perception of pain.

Pharmacodynamics

Lavang demonstrates a range of pharmacodynamic effects, including analgesic, anti-inflammatory, and antimicrobial properties. Its ability to inhibit the synthesis of prostaglandins contributes to its pain-relieving effects. Additionally, eugenol has been shown to possess antimicrobial activity against a variety of pathogens, including bacteria and fungi, making it useful in treating infections and reducing oral pain.

Pharmacokinetics

The pharmacokinetics of lavang, particularly eugenol, include rapid absorption and metabolism. After administration, eugenol is quickly absorbed into the systemic circulation, with peak plasma concentrations typically occurring within 1 to 2 hours. It is metabolized primarily in the liver, undergoing phase I and phase II metabolic reactions. The half-life of eugenol is variable but is generally reported to be between 2 to 3 hours. Excretion occurs mainly through urine, with metabolites being eliminated in both free and conjugated forms.

Pregnancy

There is limited information on the safety of lavang during pregnancy. It is advisable to consult healthcare professionals before use.

Breast-feeding

Information on the excretion of lavang in breast milk is not well-documented. Caution is recommended when administering to breastfeeding mothers.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Respiratory conditions
• Skin disorders
• Inflammation
• Pain relief
• General tonic

Dosage

Children: Refer to traditional practices and expert consultations, as specific dosing guidelines are not established.

Adults: Refer to traditional practices and expert consultations, as specific dosing guidelines are not established.

Mechanism of action

The exact mechanism of action of Nagkeshar is not fully elucidated. However, it is believed to exert its therapeutic effects through the modulation of inflammatory pathways and the inhibition of pro-inflammatory cytokines. The bioactive compounds in Nagkeshar, such as flavonoids and other phenolic compounds, may contribute to its antioxidant and anti-inflammatory activities, potentially supporting the body's natural defense mechanisms against oxidative stress and inflammation.

Pharmacodynamics

Nagkeshar demonstrates various pharmacodynamic effects, including anti-inflammatory, analgesic, and antimicrobial actions. Its anti-inflammatory properties are significant for conditions characterized by inflammation, while its analgesic effects may help alleviate pain. The antimicrobial activity of Nagkeshar is beneficial in treating infections and skin conditions caused by microbial agents. These effects are likely due to the synergistic action of its constituent phytochemicals.

Pharmacokinetics

The pharmacokinetics of Nagkeshar have not been extensively studied in humans. However, in general, herbal compounds may undergo absorption in the gastrointestinal tract after oral administration, followed by metabolism, primarily in the liver. The elimination half-life and excretion pathways remain unclear due to a lack of specific studies. Individual responses may vary based on factors such as the formulation used and the presence of other substances.

Pregnancy

The safety of nagkeshar during pregnancy has not been well studied; therefore, it should be used with caution and only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

There is insufficient data on the excretion of nagkeshar in human milk. Caution should be exercised when administering to breastfeeding women.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Allergic rhinitis
• Urticaria (hives)
• Allergic conjunctivitis
• Anaphylactic reactions (as an adjunct treatment)
• Insomnia (off-label use)

Dosage

Children: Refer to specific dosing guidelines for paediatric patients in a professional drug reference or clinical guidelines.

Adults: Refer to specific dosing guidelines for adult patients in a professional drug reference or clinical guidelines.

Mechanism of action

Nishotar acts as a competitive antagonist of histamine at H1 receptors. By binding to these receptors, it inhibits the physiological effects of histamine, including vasodilation, increased vascular permeability, and sensory nerve stimulation, which contribute to allergy symptoms. Additionally, it may cross the blood-brain barrier, exerting sedative effects by antagonizing H1 receptors in the central nervous system.

Pharmacodynamics

The pharmacodynamic effects of Nishotar include reduction of allergy symptoms such as pruritus, rhinorrhea, and conjunctival irritation. The onset of action is typically within 1 to 2 hours, and the duration of effect can last up to 24 hours, depending on the specific formulation and dose used. Sedative effects may vary among individuals due to differences in metabolism and receptor sensitivity.

Pharmacokinetics

Nishotar is well absorbed after oral administration, with peak plasma concentrations generally occurring within 1 to 3 hours. It is extensively metabolized in the liver, primarily via cytochrome P450 enzymes, and has a variable half-life ranging from 4 to 12 hours, influenced by factors such as age and liver function. The drug and its metabolites are primarily excreted in urine. The bioavailability may be affected by food intake and gastrointestinal pH.

Pregnancy

The safety of nishotar during pregnancy has not been established. It should only be used if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known whether nishotar is excreted in human breast milk. Caution should be exercised when administering to nursing mothers.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Indications

• Infertility
• Menstrual irregularities
• Hormonal imbalance
• Reproductive health support

Dosage

Children: Refer to established guidelines or consult a healthcare provider for appropriate dosing.

Adults: Refer to established guidelines or consult a healthcare provider for appropriate dosing.

Mechanism of action

The exact mechanism of action of Shivlingi is not fully understood, but it is believed to influence hormonal activity in the body. It may exert its effects through the modulation of estrogen and progesterone levels, which are critical for reproductive health. Additionally, compounds present in Shivlingi may have anti-inflammatory and antioxidant properties, contributing to its therapeutic effects.

Pharmacodynamics

Shivlingi has been observed to potentially enhance fertility and regulate menstrual cycles. The active compounds may interact with the endocrine system to promote ovulation and improve fertility outcomes. Its antioxidant properties may also help protect reproductive tissues from oxidative stress, thereby supporting overall reproductive health.

Pharmacokinetics

The pharmacokinetics of Shivlingi are not well-documented in scientific literature. However, herbal remedies are generally characterized by their complex mixtures of bioactive compounds, which may be absorbed differently in the body. Factors such as the method of preparation, dosage form, and individual patient metabolism can influence the pharmacokinetic profile, including absorption, distribution, metabolism, and excretion.

Pregnancy

The safety of shivlingi during pregnancy has not been established. It is advisable to avoid use unless prescribed by a healthcare professional.

Breast-feeding

There is insufficient data on the excretion of shivlingi in human milk. Caution is recommended when used during breastfeeding.

Storage

Store shivlingi in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Detoxification
• Rejuvenation
• Ayurvedic treatment for various ailments

Dosage

Children: Dosage should be determined by a qualified practitioner familiar with Ayurvedic medicine and individual patient needs; refer to traditional texts or guidelines.

Adults: Dosage should be determined by a qualified practitioner familiar with Ayurvedic medicine and individual patient needs; refer to traditional texts or guidelines.

Mechanism of action

The exact mechanism of action of shuddha is not well defined in modern pharmacology. However, in Ayurvedic medicine, it is believed to act as a potent detoxifier and may stimulate various metabolic processes. Mercury is thought to interact with cellular processes, potentially influencing enzyme activity and signaling pathways, although this is not well-characterized in contemporary scientific literature.

Pharmacodynamics

Shuddha's pharmacodynamics are not well studied under conventional clinical settings. In Ayurvedic texts, it is suggested that shuddha can enhance the body's ability to eliminate toxins and may exert effects on the digestive system, respiratory health, and overall vitality. The role of heavy metals like mercury in biological systems is complex and can lead to both therapeutic and toxic effects, depending on the dose and individual response.

Pharmacokinetics

The pharmacokinetics of shuddha are not well established in the literature. In general, mercury compounds can be absorbed through the gastrointestinal tract, lungs, and skin. Once in the body, mercury can distribute to various tissues, including the liver, kidneys, and brain. The elimination half-life of mercury varies depending on the form and the route of exposure, with some forms being excreted more rapidly than others. Accumulation in tissues can lead to toxicity, emphasizing the importance of careful dosing and monitoring.

Pregnancy

Consult with a healthcare professional before use.

Breast-feeding

Consult with a healthcare professional before use.

Storage

Store in a cool, dry place away from direct sunlight.